OPS y SEGIB refuerzan su alianza para una Iberoamérica más saludable e inclusiva
Cristina Mitchell
30 Jun 2025
Cristina Mitchell
30 Jun 2025
Cristina Mitchell
30 Jun 2025
FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies
http://www.fda.gov/news-events/press-announcements/fda-eliminates-risk-evaluation-and-mitigation-strategies-rems-autologous-chimeric-antigen-receptor
Cristina Mitchell
27 Jun 2025
Cristina Mitchell
27 Jun 2025
Cristina Mitchell
25 Jun 2025